Bruker (NASDAQ:BRKR) Issues FY24 Earnings Guidance

Bruker (NASDAQ:BRKR) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.36-2.41 for the period, compared to the consensus estimate of $2.59. The company issued revenue guidance of $3.34-3.37 billion, compared to the consensus revenue estimate of $3.40 billion. Bruker also updated its FY 2024 guidance to 2.360-2.410 EPS.

Wall Street Analyst Weigh In

Several research firms recently commented on BRKR. Citigroup dropped their price objective on Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a research report on Wednesday. Barclays dropped their price objective on shares of Bruker from $75.00 to $69.00 and set an “overweight” rating for the company in a report on Wednesday. Wolfe Research downgraded Bruker from an “outperform” rating to a “peer perform” rating in a research report on Monday, September 30th. TD Cowen cut their price target on Bruker from $72.00 to $70.00 and set a “hold” rating for the company in a report on Wednesday. Finally, Wells Fargo & Company lowered their target price on Bruker from $78.00 to $75.00 and set an “overweight” rating for the company in a research report on Wednesday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $79.36.

Bruker Stock Performance

Bruker stock traded down $1.93 during trading hours on Wednesday, hitting $59.41. 1,244,397 shares of the stock traded hands, compared to its average volume of 1,068,050. Bruker has a 1 year low of $54.55 and a 1 year high of $94.86. The stock has a market capitalization of $8.99 billion, a price-to-earnings ratio of 24.98, a P/E/G ratio of 2.32 and a beta of 1.20. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.65 and a quick ratio of 0.75. The firm’s 50 day moving average price is $64.08 and its 200-day moving average price is $66.56.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, November 5th. The medical research company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.01). The company had revenue of $864.40 million during the quarter, compared to analyst estimates of $866.46 million. Bruker had a net margin of 11.29% and a return on equity of 24.92%. The business’s quarterly revenue was up 16.4% compared to the same quarter last year. During the same period last year, the firm earned $0.74 EPS. As a group, equities analysts expect that Bruker will post 2.61 EPS for the current fiscal year.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Monday, September 2nd were paid a $0.05 dividend. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 annualized dividend and a yield of 0.34%. Bruker’s dividend payout ratio is currently 8.30%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.